FSCN1 and breast carcinoma: Altogether, the data presented in this study demonstrated that fascin–FAK-β-catenin axis plays a critical role in promoting breast CSC function, and the interference with this axis may thus provide an attractive approach for therapeutic targeting of breast cancer from the root.